|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Gene Promoter Polymorphism With Low Attenuation Areas on High-Resolution CT in Patients With COPD*
* From the Association of Non-University Pulmonary Specialist Physicians Affiliated to the Chiba University School of Medicine, Department of Respirology (B2) [Drs. Sakao, Tatsumi, Igari, Watanabe, and Kuriyama], and Molecular Virology (E2) [Drs. Shino and Shirasawa], Graduate School of Medicine, Chiba University, Chiba, Japan.
Correspondence to: Seiichiro Sakao, MD, Department of Respirology (B2), Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuou-ku, Chiba 260-8670, Japan; e-mail: sakao{at}virolo3.m.chiba-u.ac.jp
Study objectives: Alveolar septal cell apoptosis may contribute to the pathogenesis of emphysema. Because tumor necrosis factor (TNF)-
is assumed to play an important role in the induction of apoptosis, and allele 2 of the polymorphism at position - 308 in the promoter of the TNF-
gene has been associated with alteration of TNF-
secretion in vitro, we hypothesized that genotypes containing this allele would show more destructive emphysematous changes of the lung.
Design: The percentage ratio of the low attenuation area to the corresponding lung area was evaluated using a visual scoring system for CT findings in patients with COPD (n = 84), and these patients were classified into two groups: those with a visual score < 11 and those with a visual score
11. A polymerase chain reaction-based assay was developed to determine the TNF-
genotype (TNF-
-308*1/2) between subjects with high and low visual scores on chest CT scans.
Results: The TNF-
-308*1/2 allele frequency tended to differ between patients with a visual score < 11 (0.90/0.10) and those with a visual score
11 (0.81/0.19) [odds ratio, 2.15; 95% confidence interval, 0.87 to 5.30; p = 0.09].
Conclusion: These results indicate that the TNF-
-308 allele 2 may be partly associated with the extent of emphysematous changes in patients with COPD.
Key Words: apoptosis COPD emphysema tumor necrosis factor-
This article has been cited by other articles:
![]() |
I. Ito, S. Nagai, T. Handa, S. Muro, T. Hirai, M. Tsukino, and M. Mishima Matrix Metalloproteinase-9 Promoter Polymorphism Associated with Upper Lung Dominant Emphysema Am. J. Respir. Crit. Care Med., December 1, 2005; 172(11): 1378 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. van der Vaart, G. H. Koeter, D. S. Postma, H. F. Kauffman, and N. H. T. ten Hacken First Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 465 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. A. Lundblad, J. Thompson-Figueroa, T. Leclair, M. J. Sullivan, M. E. Poynter, C. G. Irvin, and J. H. T. Bates Tumor Necrosis Factor-{alpha} Overexpression in Lung Disease: A Single Cause behind a Complex Phenotype Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1363 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Molfino Genetics of COPD Chest, May 1, 2004; 125(5): 1929 - 1940. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ito, S. Nagai, Y. Hoshino, S. Muro, T. Hirai, M. Tsukino, and M. Mishima Risk and Severity of COPD Is Associated With the Group-Specific Component of Serum Globulin 1F Allele Chest, January 1, 2004; 125(1): 63 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.M.W.J. Schols Nutritional and metabolic modulation in chronic obstructive pulmonary disease management Eur. Respir. J., November 2, 2003; 22(46_suppl): 81S - 86s. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sakao, K. Tatsumi, T. Hashimoto, H. Igari, Y. Shino, H. Shirasawa, and T. Kuriyama Vascular Endothelial Growth Factor and the Risk of Smoking-Related COPD Chest, July 1, 2003; 124(1): 323 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Lio, L Scola, A Crivello, G Colonna-Romano, G Candore, M Bonafe, L Cavallone, F Marchegiani, F Olivieri, C Franceschi, et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-{alpha} -308 promoter SNP J. Med. Genet., April 1, 2003; 40(4): 296 - 299. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |